TherapeuticsMD Inc (TXMD)
TherapeuticsMD, Inc. is a common stock listing on NASDAQ under the ticker TXMD. The company operates in the U.S. pharmaceutical sector and describes itself as a pharmaceutical royalty company. Through a license agreement with Mayne Pharma, it has commercial rights associated with IMVEXXY, BIJUVA, and ANNOVERA, which are sold alongside prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. Its products are distributed through wholesale and retail pharmacy channels. TherapeuticsMD was founded in 2008 and is headquartered in Boca Raton, Florida.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TXMD
|
$1.86
|
-9.8% Downside
|
Fair
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
August 17, 2026
|
277.9x
|
0.9x
|
7.1x
|
24.422 M
|
21.313 M
|
19.3%
|
82.0%
|
-37.6
|
—
|
3,109.3%
|
